Clinical Science Review: Estrogen Use and Cancer Incidence: A Review

References

• Beatson G. On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases. Lancet 1896; 2: 104–107; 162–165
   Google Scholar
• Lacassagne A. Apparition de cancers de la mamelle chez la souris mâle, soumise à des injections de folliculine. C R Acad Sci (Paris) 1932; 195: 630–632
   Google Scholar
• Furth J. Hormones as etiological agents in neoplasia. Cancer, F Becker. Plenum Press, New York 1982; Vol I: 89–134
   Google Scholar
• Gardner WU. Hormonal aspects of experimental tumorigenesis. Advances in Cancer Research, J Greenstein, A Haddow. Academic Press, New York 1953; vol I: 173–232
   Google Scholar
• Lipschütz A. Steroid Hormones and Tumors. Williams & Wilkins, Baltimore 1950; 98–121
   Google Scholar
• Lupulescu A. Steroid Hormones. Med. Publ. House, Bucharest 1958; 229–248
   Google Scholar
• Lupulescu A. Hormones and Carcinogenesis. Praeger Scientific, New York 1983; 89–144
   Google Scholar
• Barrett-Connor E. Risks and benefits of replacement estrogen. Annu Rev Med 1992; 43: 239–251
   PubMed Web of Science ®Google Scholar
• Gambrell RD. Update on hormone replacement therapy. Am Fam Physician 1992; 46: 87–96, (suppl. 5)
   Google Scholar
• Grady D, Rubin SZ, Petitti D. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–1036
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861–1867
   PubMed Web of Science ®Google Scholar
• Martin KA, Freeman MW. Postmenopausal hormone replacement therapy. N Engl J Med 1993; 328: 1115–1117
   PubMed Web of Science ®Google Scholar
• Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer. Cancer Res 1988; 48: 246–253
   PubMed Web of Science ®Google Scholar
• Jacobs HS, Loeffler FE. Postmenopausal hormone replacement therapy. BMJ 1992; 305: 1403–1408
   PubMed Web of Science ®Google Scholar
• Voigt LF, Weiss NS, Chu J. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991; 338: 274–277
   PubMed Web of Science ®Google Scholar
• Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151: 67–72
   PubMed Web of Science ®Google Scholar
• Van Leeuwen FE, Rookus MA. The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer. Eur J Cancer Clin Oncol 1961–1972, 1989; 25
   Google Scholar
• Lupulescu A. Hormones and Vitamins in Cancer Treatment. CRC Press, Boca Raton, FL 1990; 33–90
   Google Scholar
• Wingfield M. The daughters of stilbestrol. BMJ 1991–1992, 1991; 302
   PubMed Web of Science ®Google Scholar
• Colton T, Greenberg ER, Noller K. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. JAMA 1993; 269: 2096–2100
   PubMed Web of Science ®Google Scholar
• Evaluation of Carcinogenic Risks to Humans: Oestrogens. Progestins and Combinations, IARC Monographs Suppl 7. International Agency for Research Cancer, Lyon (France) 1987; 272–310
   Google Scholar
• Lupulescu A. Hormonal regulation of epidermal tumor development. J Invest Dermatol 1981; 77: 186–195
   PubMed Web of Science ®Google Scholar
• Lacassagne A. Les hormones et leurs relations avec le cancer. Schweiz Med Wochenschr 1948; 78: 705–708
   PubMedGoogle Scholar
• Lacassagne A, Raynaud A. Sur le méchanisme d'une action préventive de la testosterone sur le carcinome mammaire de la souris. C R Soc Séances Soc Biol Fil (Paris) 1939; 131: 586–588
   Google Scholar
• Huggins C, Moon R, Morii S. Extinction of experimental mammary cancer I Estradiol-17β and progesterone. Proc Natl Acad Sci USA 1962; 48: 379–386
   PubMed Web of Science ®Google Scholar
• Preston-Martin S, Pike MC, Ross RK. Increased cell division as a cause of human cancer. Cancer Res 1990; 50: 7415–7421
   PubMed Web of Science ®Google Scholar
• Lannigan DA, Notides AC. Estrogen regulation of transcription. Molecular Endocrinology and Steroid Hormone Action, GH Sato, JL Stevens. Alan R Liss, New York 1990; 187–197
   Google Scholar
• Lupulescu A. Hormonal regulation of DNA synthesis in cancer epidermal cells. J Cell Biol 1980; 87: 103
   Google Scholar
• Lupulescu A, Rogers J, Birmingham D. Hormonal control of preneoplastic epidermal cells during carcinogenesis in mice. J Cell Biol 1978; 79: 187
   Google Scholar
• Rochefort H, Capony F, Garcia M. Estrogen-induced lysosomal proteases secreted by breast cancer cells. A role in carcinogenesis?. J Cell Biochem 1987; 35: 17–29
   PubMed Web of Science ®Google Scholar
• Cohen SM, Ellwein LB. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 1991; 51: 6493–6505
   PubMed Web of Science ®Google Scholar
• Telang NT, Suto A, Wong GY. Induction by estrogen metabolite 16α-hydroxy-estrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992; 84: 634–638
   PubMed Web of Science ®Google Scholar
• De Sombre ER. Estrogens, receptors and cancer. Molecular Endocrinology and Steroid Hormone Action, GH Sato, JL Stevens. Alan R Liss, New York 1990; 17–29
   Google Scholar
• Jiang SY, Jordan VC. Growth regulation of estrogen receptornegative breast cancer cells transfected with complimentary DNAs for estrogen receptor. J Natl Cancer Inst 1992; 84: 580–591
   PubMed Web of Science ®Google Scholar
• Cullick WJ. Growth factors and oncogenes in breast cancer. Prog Growth Factor Res 1990; 2: l–13
   Google Scholar
• Stoler AB. Genes and cancer. Br Med Bull 1991; 47: 64–75
   PubMed Web of Science ®Google Scholar
• Seshadri R, Matthews C, Dobrovic A. The significance of oncogene amplification in primary breast cancer. Int J Cancer 1989; 43: 270–272
   PubMed Web of Science ®Google Scholar
• Treurniet HF, Rookus MA, Peterse HL. Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor. Cancer Res 1992; 52: 2344–2345
   PubMed Web of Science ®Google Scholar
• Read LD., Keith D, Slamon DJ. Hormonal modulation of HER-2/neu proto-oncogenes messenger ribonucleic acid and p 185 protein expression in human breast cancer cell lines. Cancer Res 1990; 50: 3947–3951
   PubMed Web of Science ®Google Scholar
• Wärri AM, Laine AM, Majasuo KE. Estrogen suppression of erb B2 expression is associated with increased growth rate of ZR-75–1 human breast cancer cells in vitro and in nude mice. Int J Cancer 1991; 49: 616–623
   PubMed Web of Science ®Google Scholar
• Papa M, Mezzogiorno V., Bresciani F. Estrogen induces c-fos expression specifically in the luminal and glandular epithelia of adult rat uterus. Biochem Biophys Res Commun 1991; 175: 480–485
   PubMed Web of Science ®Google Scholar
• Scrocchi LA., Jones LA. Alteration of proto-oncogene c-fos expression in neonatal estrogenized BALB/c female and murine cervicovaginal tumor LJ 6195. Endocrinology 1991; 129: 2251–2253
   PubMed Web of Science ®Google Scholar
• Lau CK, Subramaniam M, Rasmussen K. Rapid inhibition of the c-jun proto-oncogene expression in avian oviduct by estrogen. Endocrinology 1990; 127: 2595–2597
   PubMed Web of Science ®Google Scholar
• Dreicer R, Wilding G. Steroid hormone agonists and antagonists in the treatment of cancer. Cancer Invest 1992; 10: 27–41
   PubMed Web of Science ®Google Scholar
• Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science 1993; 259: 633–638
   PubMed Web of Science ®Google Scholar
• Waxman J. A new understanding of the hormonal regulation of endocrine dependent cancer. Br Med Bull 1991; 47: 197–208
   PubMed Web of Science ®Google Scholar
• Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29–43
   PubMedGoogle Scholar
• Henrich JB. The postmenopausal estrogen/breast cancer controversy. JAMA 1900–1902, 1992; 268
   Google Scholar
• Seeley T. Oestrogen replacement therapy after hysterectomy. BMJ 1992; 305: 811–812
   PubMed Web of Science ®Google Scholar
• Nachtigall MJ, Srnilen SW, Nachtigall RD. Incidence of breast cancer in a 22-year study of women receiving estrogenprogestin replacement therapy. Obstet Gynecol 1992; 80: 827–830
   PubMed Web of Science ®Google Scholar
• Nayfield SG, Karp JE, Ford LG. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991; 83: 1450–1459
   PubMed Web of Science ®Google Scholar
• Godwin AK, Testa JR, Hamilton TC. The biology of ovarian cancer development. Cancer 1993; 71: 530–536
   PubMed Web of Science ®Google Scholar
• Yager JD, Zurlo I, Ni N. Sex hormones and tumor promotion in liver. Proc Soc Exp Biol Med 1991; 198: 667–675
   PubMed Web of Science ®Google Scholar
• Prentice RL. Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers. Prev Med 1991; 20: 38–46
   PubMed Web of Science ®Google Scholar
• Hart JE. Endocrine pathology of estrogens: Species differences. Pharmacol Ther 1990; 47: 203–218
   PubMed Web of Science ®Google Scholar